This month, DevicePharm finds itself in exceptional company—ranked among the top 100 Medical Advertising Agencies in North America (based on estimated revenues) by the magazine, Medical Marketing & Media (MM&M) in their 100 Agencies issue.
In compiling their list for the July 2012 issue, the editors of MM&M drew upon hundreds of hours of research by eight journalists, including more than 120 extensive interviews with some of North America’s top healthcare marketing agency leaders. The net result is the single largest issue in the publication’s entire 47-year history, which provides an insightful, 224-page glimpse of an industry in rapid transition.
Going well beyond a mere “laundry list” of clients and services, MM&M’s writers deliver a snapshot of the personality and leadership of each listed agency, as well as they’re reacting to, embracing, and/or helping to shape “digital age” agendas.
Digital Done A Bit Differently
In 100 Agencies, DevicePharm’s management team describes its decidedly more pragmatic approach to all things digital. “With things changing so quickly in the digital space, the key is not to always jump on the next communication channel, but to ensure you’re going to get a return,” advises agency President Jon Hermie. “For example, we worked with Baxter Biosurgery to aggressively implement digital marketing. We’ve significantly grown their web presence for medical education and brand promotion.”
“We provide digital services for nearly all of our clients now,” elaborates Clay Wilemon, DevicePharm CEO. “The efficiency of digital selling platforms—particularly with iPads and their adaptability to capture customer management information and take advantage of new data—really lends itself to a broad digital application with our clients.”
Change: Agencies Evolving, Rebranding, and Reinventing
Also documented by 100 Agencies is how many agencies are reacting to industry changes by scrambling to evolve, rebrand, or even reinvent themselves via everything from investing in analytics and building out capabilities to restructuring divisions, acquiring tech partners, and/or expanding their global footprints. Choosing to define his agency’s plan for success in decidedly more client-friendly terms, DevicePharm CEO Clay Wilemon reflects, “At our foundation, we are a strong, strategic marketing partner. The key to our success continues to be providing our clients with strategic positioning and core marketing work.”
Read the entire story here.
